par Curigliano, Giuseppe;Cardinale, D;Suter, T.;Plataniotis, G;de Azambuja, Evandro ;Sandri, Maria Teresa;Criscitiello, Carmen ;Goldhirsch, Aron;Cipollari, Chiara;Roila, F;ESMO Guidelines Working Group,
Référence Annals of oncology, 23 Suppl 7, page (vii155-vii166)
Publication Publié, 2012-10
Référence Annals of oncology, 23 Suppl 7, page (vii155-vii166)
Publication Publié, 2012-10
Article révisé par les pairs
Titre: |
|
Auteur: | Curigliano, Giuseppe; Cardinale, D; Suter, T.; Plataniotis, G; de Azambuja, Evandro; Sandri, Maria Teresa; Criscitiello, Carmen; Goldhirsch, Aron; Cipollari, Chiara; Roila, F; ESMO Guidelines Working Group, |
Informations sur la publication: | Annals of oncology, 23 Suppl 7, page (vii155-vii166) |
Statut de publication: | Publié, 2012-10 |
Sujet CREF: | Cancérologie |
MeSH keywords: | Antineoplastic Agents -- adverse effects -- therapeutic use |
Heart -- drug effects -- physiopathology -- radiation effects | |
Heart Diseases -- chemically induced -- physiopathology -- prevention & control | |
Humans | |
Needs Assessment | |
Neoplasms -- drug therapy -- radiotherapy | |
Radiation Injuries | |
Note générale: | Journal Article |
Practice Guideline | |
Research Support, Non-U.S. Gov't | |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:0923-7534 |
info:doi/10.1093/annonc/mds293 | |
info:pii/mds293 | |
info:scp/84866599720 | |
info:pmid/22997448 |